Clinical Trial Update: Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 study investigating the mechanism of action of tofacitinib (CP-690,550) in the skin of adults with moderate to severe chronic plaque psoriasis. Results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2015-04-13